Essentials in the management of necrotizing soft-tissue infections.
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
02
04
2019
accepted:
30
04
2019
pubmed:
12
5
2019
medline:
13
11
2019
entrez:
12
5
2019
Statut:
ppublish
Résumé
Necrotizing soft-tissue infections (NSTI) are rare but severe diseases with rapid progression. Rates of mortality and morbidity are high and early diagnosis, immediate surgical intervention and antibiotic treatment are essential to improve prognosis. Thus, our commentary emphasizes important information in the management of NSTI. We describe the essentials in the management of necrotizing soft-tissue infections. Six essentials were identified: 1. Necrotizing soft-tissue infections (NSTI) are primarily diagnosed clinically; pain out of proportion, rapid progression of skin infection and systemic signs should alert clinicians. 2. Early diagnosis can be rather delayed by several factors such as absence of fever, significant cutaneous manifestations, elevation of inflammatory parameters, systemic signs, and non-specific imaging tests. 3. NSTI can occur both in the elderly or patients with underlying diseases after major trauma (usually polymicrobial Gram-negative and Gram-positive pathogens) but also in healthy patients after minor trauma (often monomicrobial; most common among Gram-positive organisms: group A Streptococcus). 4. Immediate and radical debridement (incl. re-debridement after 24 h) remains the cornerstone of surgical therapy. 5. Empirical broad-spectrum antimicrobial treatment has to be administered shortly after admission. After isolation of the causative bacteria therapy should be tailored. 6. The value of adjunctive measures (hyperbaric oxygen therapy, intravenous immunoglobulines) is uncertain and their routine use cannot be recommended. Further efforts should be undertaken to increase the awareness for and the adherence to the essentials in the management of necrotizing soft-tissue infections.
Identifiants
pubmed: 31077024
doi: 10.1007/s15010-019-01316-3
pii: 10.1007/s15010-019-01316-3
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
677-679Références
Crit Care Med. 2004 Jul;32(7):1535-41
pubmed: 15241098
Int J Dermatol. 2007 Oct;46(10):1036-41
pubmed: 17910710
J Burn Care Res. 2009 Mar-Apr;30(2):301-6
pubmed: 19165118
Surg Infect (Larchmt). 2009 Oct;10(5):467-99
pubmed: 19860574
Am J Surg. 2013 Jul;206(1):32-9
pubmed: 23414632
Br J Surg. 2014 Jan;101(1):e119-25
pubmed: 24338771
Clin Infect Dis. 2014 Jul 15;59(2):e10-52
pubmed: 24973422
World J Emerg Surg. 2014 Nov 18;9(1):57
pubmed: 25422671
Cochrane Database Syst Rev. 2015 Jan 15;1:CD007937
pubmed: 25879088
Int J Infect Dis. 2015 Jul;36:15-20
pubmed: 25975653
Curr Opin Infect Dis. 2016 Apr;29(2):139-44
pubmed: 26779777
J Infect Dis. 2017 Jan 15;215(2):269-277
pubmed: 27247345
Intensive Care Med. 2017 Nov;43(11):1585-1593
pubmed: 28421246
N Engl J Med. 2017 Dec 7;377(23):2253-2265
pubmed: 29211672
Br J Radiol. 2018 Jul;91(1088):20180093
pubmed: 29537292
Infection. 2018 Jun;46(3):395-404
pubmed: 29667040
Infection. 2018 Aug;46(4):577
pubmed: 29728837
Cochrane Database Syst Rev. 2018 May 31;5:CD011680
pubmed: 29851032